OneDigital Investment Advisors LLC Makes New Investment in Avantor, Inc. $AVTR

OneDigital Investment Advisors LLC purchased a new stake in Avantor, Inc. (NYSE:AVTR) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 142,922 shares of the company’s stock, valued at approximately $1,415,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Wellington Management Group LLP acquired a new stake in shares of Avantor in the fourth quarter worth approximately $268,584,000. Morgan Stanley increased its position in Avantor by 179.4% during the fourth quarter. Morgan Stanley now owns 17,468,418 shares of the company’s stock worth $200,188,000 after purchasing an additional 11,216,565 shares during the last quarter. Engine Capital Management LP increased its position in Avantor by 65.8% during the first quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock worth $155,082,000 after purchasing an additional 7,853,018 shares during the last quarter. Norges Bank purchased a new position in Avantor during the fourth quarter worth approximately $73,322,000. Finally, Bank of New York Mellon Corp purchased a new position in Avantor during the second quarter worth approximately $40,800,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Down 1.0%

Shares of AVTR stock opened at $13.52 on Tuesday. The stock has a market cap of $9.14 billion, a price-to-earnings ratio of -16.10, a price-to-earnings-growth ratio of 10.29 and a beta of 0.89. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.65. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The firm’s 50 day moving average price is $11.28 and its two-hundred day moving average price is $9.55.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.02. Avantor had a negative net margin of 8.81% and a positive return on equity of 9.92%. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.61 billion. During the same quarter in the prior year, the business earned $0.24 earnings per share. The business’s quarterly revenue was up .5% compared to the same quarter last year. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. On average, analysts anticipate that Avantor, Inc. will post 0.81 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a report on Thursday, April 30th. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 price objective for the company in a report on Wednesday, July 29th. Barclays increased their target price on Avantor from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, June 24th. UBS Group set a $8.00 target price on Avantor in a report on Wednesday, June 24th. Finally, Citigroup boosted their price target on Avantor from $9.00 to $11.00 and gave the company a “neutral” rating in a research report on Wednesday, July 8th. Two investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $12.00.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.